Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3974651, 7 pages
https://doi.org/10.1155/2017/3974651
Research Article

Tuberculosis Treatment Outcomes and Factors Associated with Each of Them in a Cohort Followed Up between 2010 and 2014

1Postgraduate Program Clinical Research in Infectious Diseases, National Institute of Infectious Diseases Evandro Chagas-Fiocruz, Manguinhos, RJ, Brazil
2Clinical Research Laboratory on Immunizations and Surveillance, National Institute of Infectious Diseases Evandro Chagas-Fiocruz, Manguinhos, RJ, Brazil
3Clinical Research Laboratory on Mycobacteria, National Institute of Infectious Diseases Evandro Chagas-Fiocruz, Manguinhos, RJ, Brazil

Correspondence should be addressed to Valeria C. Rolla; moc.liamg@allor.airelav

Received 11 August 2017; Revised 25 November 2017; Accepted 7 December 2017; Published 28 December 2017

Academic Editor: Isabel Portugal

Copyright © 2017 Mayara A. Cardoso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Global Tuberculosis Report,” 2016.
  2. Ministério da Saúde do Brasil, “Apresentacao sobre os principais indicadores da tuberculose”.
  3. A. Castelo Filho, A. L. Kritski, Â. W. Barreto et al., “II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004,” Jornal Brasileiro De Pneumologia, vol. 30, pp. S57–S86, 2004. View at Google Scholar
  4. M. B. Conde, F. A. F. de Melo, A. M. C. Marques et al., “III Brazilian thoracic association guidelines on tuberculosis,” Jornal Brasileiro de Pneumologia, vol. 35, no. 10, pp. 1018–1048, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Ministério Da Saúde Do Brasil, Protocolo Clínico e Diretrizes Terapêuticas para o Manejo da Iinfecção pelo HIV em Adultos, 2017, http://conitec.gov.br/images/Protocolos/PCDT_Manejo-HIV-Adultos_2013.pdf.
  6. J. U. Braga and A. Trajman, “Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study,” BMC Infectious Diseases, vol. 15, p. 81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. S. Schmaltz, F. M. Sant'Anna, S. C. Neves et al., “Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 5, pp. 623–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. S. Schmaltz, G. Santoro-Lopes, M. C. Lourenço, M. G. Morgado, L. S. de Velasque, and V. C. Rolla, “Factors Impacting Early Mortality in Tuberculosis/HIV Patients: Differences between Subjects Naïve to and Previously Started on HAART,” PLoS ONE, vol. 7, no. 9, Article ID e45704, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Tereza Campello and Marcelo Côrtes Ner, Bolsa Família Program: a decade of social inclusion in Brazil, IPEA, 2014, Executive Summary.
  10. J. S. Nery, L. C. Rodrigues, D. Rasella et al., “Effect of Brazil's conditional cash transfer programme on tuberculosis incidence,” The International Journal of Tuberculosis and Lung Disease, vol. 21, no. 7, pp. 790–796, 2017. View at Publisher · View at Google Scholar
  11. A. W. Torrens, D. Rasella, D. Boccia et al., “Effectiveness of a conditional cash transfer programme on TB cure rate: A retrospective cohort study in Brazil,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 110, no. 3, Article ID trw011, pp. 199–206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. K. R. De Camargo, C. R. Guedes, R. Caetano, A. Menezes, and A. Trajman, “The adoption of a new diagnostic technology for tuberculosis in two Brazilian cities from the perspective of patients and healthcare workers: A qualitative study Health systems and services in low and middle income settings,” BMC Health Services Research, vol. 15, no. 1, article no. 275, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. B. N. Muture, M. N. Keraka, P. K. Kimuu, E. W. Kabiru, V. O. Ombeka, and F. Oguya, “Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: A case control study,” BMC Public Health, vol. 11, article no. 696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Albanna, B. M. Smith, D. Cowan, and D. Menzies, “Fixed-dose combination antituberculosis therapy: A systematic review and meta-analysis,” European Respiratory Journal, vol. 42, no. 3, pp. 721–732, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Nunn, S. V. Cook, M. Burgos et al., “Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis,” The International Journal of Tuberculosis and Lung Disease, vol. 18, no. 10, pp. 1252–1254, 2014. View at Publisher · View at Google Scholar · View at Scopus